Canada Markets closed

Aurora Cannabis Inc. (ACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.6973+0.0321 (+4.83%)
At close: 04:00PM EDT
0.6900 -0.01 (-1.05%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.6652
Bid0.6850 x 800
Ask0.6900 x 4000
Day's Range0.6700 - 0.7200
52 Week Range0.6550 - 4.2000
Avg. Volume6,147,625
Market Cap227.576M
Beta (5Y Monthly)2.99
PE Ratio (TTM)N/A
EPS (TTM)-15.7490
Earnings DateMay 10, 2023 - May 15, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.06
  • CNW Group

    Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

    Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $46.6 million (US$34.3 million) principal amount of its convertible senior notes ("Notes") at a total cost, including accrued interest, of $45.6 million (US$33.6 million) in cash, saving $2.6 million in annualized interest payments. Following completion of this repurchase, Aurora will have approximatel

  • Motley Fool

    Don't Buy the Hype: Aurora Cannabis' Transformation Hasn't Worked

    Restructuring and changes in strategy are moves that businesses often deploy when they're facing challenges and headwinds. While Aurora Cannabis (NASDAQ: ACB) has been slashing costs and changing its operations in recent years, the company isn't out of the woods by any stretch. Among the biggest moves that Aurora has made in recent years has been to shift its business more toward medical marijuana.

  • Motley Fool

    2 Reasons to Buy Aurora Cannabis and 1 Reason to Sell It

    Aurora Cannabis (NASDAQ: ACB) is one of the few Canadian cannabis retailers that is still seeing revenue growth, despite price compression and illegal sales negatively impacting the industry. The company is still losing money, but it appears to be edging its way toward profitability. Aurora's path to success includes branching out to international markets while focusing more on medical marijuana sales at home.